Evidence map›Paper›PMID 36038347›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[Analysis and significance of HBV DNA below the lower detection limit of HBV RNA levels after long-term NAs antiviral therapy in patients with hepatitis B virus cirrhosis].

C Y Wang, Y Cao, Y M Feng, J Li, B Jiang, Y Zhang, J Wen, Y J Zhu, J Li

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

C Y WangDepartment of Chronic Liver Disease,Tianjin Second People's Hospital, Tianjin 300192, China.
Y CaoHepatopathy Research Institute, Tianjin Second People's Hospital, Tianjin 300192, China.
Y M FengDepartment of Chronic Liver Disease,Tianjin Second People's Hospital, Tianjin 300192, China.
J LiGraduate School of Tianjin Medical University, Tianjin 300192, China.
B JiangHepatopathy Research Institute, Tianjin Second People's Hospital, Tianjin 300192, China.
Y ZhangDepartment of Chronic Liver Disease,Tianjin Second People's Hospital, Tianjin 300192, China.
J WenDepartment of Chronic Liver Disease,Tianjin Second People's Hospital, Tianjin 300192, China.
Y J ZhuGraduate School of Tianjin Medical University, Tianjin 300192, China.
J LiDepartment of Chronic Liver Disease,Tianjin Second People's Hospital, Tianjin 300192, China.
Tianjin People's Hospital · CNTianjin Medical University · CN

Funding

Tianjin Youth Science Fund 18JCQNJCH800
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B, ChronicHepatitis B virusAntiviral AgentsDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensHumansLimit of DetectionLiver CirrhosisPlant ExtractsRNAAntiviral AgentsDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensnasPlant ExtractsRNA

Identifiers

PMID36038347
PMCPMC12769644
OpenAlexW4293678853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.